About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Seattle | 11,370 Studies Near You

Clinical TrialsSeattle

Clinical Trials in Seattle

Discover 11,370 clinical trials near Seattle, Washington. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4881-4900 of 11,370 trials

CompletedT-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)This research study is a Phase II clinical trial.NCT01853748·Birmingham, Alabama and 84 others

Find Trials by Condition in Seattle

Breast Cancerin Seattle Lung Cancerin Seattle Prostate Cancerin Seattle Colorectal Cancerin Seattle Melanomain Seattle Leukemiain Seattle Lymphomain Seattle Pancreatic Cancerin Seattle Ovarian Cancerin Seattle Brain Cancerin Seattle Diabetes

Data from ClinicalTrials.govTerms

CompletedEfficacy and Safety of AG10 in Subjects With Transthyretin Amyloid CardiomyopathyPhase 3 efficacy and safety study to evaluate acoramidis (AG10) HCl 800 mg administered orally twice a day compared to placebo in subjects with symptomatic Transthyretin Amyloid…NCT03860935·Los Angeles, California and 103 others

CompletedEvaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited DeficiencyThe trial is conducted in Europe, North America and Asia.NCT00713648·Phoenix, Arizona and 34 others

RecruitingSLV-154 Treatment of Advanced CancersThis is a Phase 1 study comprising a Phase 1a dose-escalation portion and a Phase 1b expansion portion evaluating the safety, pharmacokinetics, pharmacodynamics, immunogenicity…NCT06771219·Newport Beach, California and 11 others

CompletedThe Effective of Immersive Virtual Reality Distraction on Memory: Study 1The effect of virtual reality on memory.NCT07172230·Seattle, Washington

TerminatedNeoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal CancerThis trial will enroll patients with locally advanced rectal cancer (resectable and non-resectable).The phase Ib dose escalation portion of trial is designed to determine the…NCT02010567·Denver, Colorado and 5 others

CompletedAC220 for Children With Relapsed/Refractory ALL or AMLThis is a phase I study of the investigational drug AC220 combined with cytarabine and etoposide in pediatric patients with relapsed acute lymphoblastic leukemia (ALL) and acute…NCT01411267·Los Angeles, California and 10 others

CompletedSurgery in Treating Children With NeuroblastomaRATIONALE: Surgery alone may be effective in treating children with neuroblastoma.NCT00003119·Birmingham, Alabama and 234 others

RecruitingStudy of CTO1681 for the Prevention and Treatment of CRS in Patients Receiving CAR T-Cell TherapyThis is an interventional study to evaluate the use of CTO1681 in preventing or reducing CAR T-cell-induced toxicities like cytokine release syndrome (CRS).NCT05905328·Orange, California and 5 others

Active not recruitingPediatric cGVHD Symptom ScaleBackground: Some children/adolescents who have had a stem cell transplant live with chronic graft-versus-host-disease (cGVHD). cGVHD is a side effect of the transplant that can…NCT04044365·Phoenix, Arizona and 16 others

CompletedTotal-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic CancerRATIONALE: Adjusting the dose of drugs used in chemotherapy such as cyclophosphamide may decrease side effects while stopping cancer cells from dividing so they stop growing or…NCT00062140·Seattle, Washington

RecruitingTreatment With Endovascular Intervention for STroke Patients With Existing DisabilityTESTED will compare the risks and benefits of endovascular thrombectomy (EVT) to medical management (no EVT) in ischemic stroke patients who have a blockage in one of the large…NCT05911568·Birmingham, Alabama and 34 others

CompletedNivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung CancerThis partially randomized phase II trial studies how well nivolumab, cabozantinib s-malate, and ipilimumab work in treating patients with stage IV non-small cell lung cancer that…NCT03468985·Anchorage, Alaska and 467 others

CompletedSU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell CarcinomaThe purpose of this study is to test whether SU011248 has activity and is safe compared to interferon-alfa as first-line therapy in patients with metastatic renal cell carcinoma…NCT00083889·Jonesboro, Arkansas and 122 others

CompletedTemsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian CancerThis phase II trial studies how well temsirolimus, carboplatin, and paclitaxel as first-line therapy works in treating patients with newly diagnosed stage III-IV clear cell…NCT01196429·Phoenix, Arizona and 144 others

CompletedDose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV PatientsParticipants with genotype 1 HCV infection were randomized to 1 of 3 sofosbuvir doses (100 mg, 200 mg, or 400 mg) or matching placebo once daily based upon stratification for…NCT01054729·San Francisco, California and 6 others

CompletedEffectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected AdultsPalifermin is a modified version of a naturally occurring human growth factor that is currently approved by the FDA to treat blood cancers.NCT00376935·Los Angeles, California and 21 others

CompletedOpen Label Extension Study of Epratuzumab in Subjects With Systemic Lupus ErythematosusThe primary objective of the study is assess the safety and tolerability of long-term epratuzumab treatment in subjects with Systemic Lupus Erythematosus (SLE)NCT01408576·Birmingham, Alabama and 227 others

Enrolling by invitationAn Open-label Study of XEN1101 in EpilepsyThis study will evaluate the long term safety, tolerability, pharmacokinetics (PK), and efficacy of XEN1101 in subjects with Focal Onset Seizures (FOS) or Primary Generalized…NCT05718817·Phoenix, Arizona and 151 others

CompletedThe Efficacy and Tolerability of NP101 Patch in the Treatment of Acute MigraineThis study was a randomized, parallel group, double-blind, placebo controlled design to compare the efficacy and tolerability of NP101 to a placebo iontophoretic transdermal patch.NCT00724815·Phoenix, Arizona and 33 others

PreviousPage 245 of 569Next

in Seattle

Heart Diseasein Seattle